-
Negative Control Outcomes in Observational Studies of Effectiveness
Jun 18, 2025, 13:39 PM -
Why Elicit Utility Weights For Cost Effectiveness Analysis Using DCEs?
Jun 17, 2025, 11:49 AM -
ISPOR HEOR Competencies: Boosting Career and Networks
Jun 12, 2025, 12:15 PM -
ADHD, GLP-1s, & HIV: Real-World Trends in Prescribing and Adherence
Jun 11, 2025, 14:37 PM -
Causal AI in HEOR: Beyond Predictions to Actionable Insights
Apr 24, 2025, 10:37 AM -
Challenges in Defining Elements of Value in DMD for Decision Making
Mar 25, 2025, 15:33 PM -
Impact of Delayed Patient Access to Cancer Treatment
Mar 18, 2025, 16:26 PM -
Defining Patient-Facing DHIs With the PICOTS-ComTeC Framework
Feb 19, 2025, 10:21 AM -
MASLD/MASH: Clinical and Economic Findings from 40-year Follow-Up Data
Dec 10, 2024, 11:14 AM -
Leveraging the Value of Clinical Outcomes in DMD for Decision Making
Dec 4, 2024, 13:20 PM -
The Burden of Time: MS Treatment and Socio-Economic Impact Reduction
Oct 30, 2024, 15:17 PM -
IRA Part III: Medicare’s Maximum Fair Prices for the First 10 Negotiated Drugs and Anticipated Cost Savings
Oct 22, 2024, 15:12 PM -
Evidence Generation for JCAs: How Can AI Boost Efficiency and Maintain Quality?
Oct 16, 2024, 15:01 PM -
Global Perspective on Inequality Aversion: Methods and Learnings
Oct 16, 2024, 11:32 AM -
Patient Involvement in Value and Health Technology Assessment (V/HTA)
Oct 10, 2024, 15:05 PM -
Conducting Research and Survey Studies in Hard-to-Reach Populations
Oct 9, 2024, 14:05 PM -
Can GenAI for Literature Reviews Ever Be Trusted? A Pragmatic Approach That’s Ethically Designed and Purpose-built for HEOR Professionals
Oct 3, 2024, 16:38 PM -
Transferability of Data and Methods to Central and Eastern Europe
Sep 19, 2024, 12:53 PM -
Moving Toward Universal Health Coverage in Africa: The Role of HTA
Aug 22, 2024, 14:15 PM -
The Role of RWE for Devices and Diagnostic Market Access in Europe
Jul 9, 2024, 12:44 PM